KEGG: pva:Pvag_2816
STRING: 712898.Pvag_2816
Recombinant Pantoea vagans Protein AaeX (aaeX) is a membrane protein derived from Pantoea vagans strain C9-1 (previously classified as Pantoea agglomerans strain C9-1). The protein consists of 67 amino acids with the sequence: MSVLPVFVMFGLSFPPVFIELIISLMLFWLVKRVLTPSGIYDLVWHPALFNTALYCCVFYLVSRLLV . The protein has a UniProt accession number E1SFM6 and appears to function as a transmembrane protein, though its specific cellular role remains under investigation.
The hydrophobic amino acid composition suggests it contains membrane-spanning domains, with the predominance of leucine, valine, and phenylalanine residues indicating potential membrane integration. Current structural studies indicate it likely adopts an alpha-helical conformation within bacterial membranes, typical of many bacterial membrane transport proteins.
For optimal expression of Recombinant Pantoea vagans Protein AaeX, researchers should consider:
E. coli-based systems: Most commonly used for initial expression trials, particularly BL21(DE3) or Rosetta strains for membrane proteins. Codon optimization may be necessary as Pantoea and E. coli have different codon usage patterns.
Cell-free expression systems: These can be advantageous for membrane proteins like AaeX that may be toxic to host cells when overexpressed.
Yeast expression systems: Pichia pastoris or Saccharomyces cerevisiae can provide eukaryotic post-translational modifications if needed.
The expression methodology should include:
Cloning the aaeX gene into an appropriate vector with a strong, inducible promoter
Incorporating affinity tags (His6, GST, or FLAG) to facilitate purification
Optimizing induction conditions (temperature, inducer concentration, and duration)
Implementing proper membrane protein extraction protocols using mild detergents
A multi-step purification strategy is recommended for obtaining high-purity Recombinant Pantoea vagans Protein AaeX:
Solubilize membrane fractions using appropriate detergents (e.g., n-dodecyl-β-D-maltoside or CHAPS)
Centrifuge at >100,000×g to remove insoluble material
Apply ion-exchange chromatography (IEX) as an initial capture step, which remains one of the most effective methods for initial protein separation
For AaeX, a strong anion exchanger is recommended at pH 7.5-8.0 based on its predicted isoelectric point
Elute using a gradient of increasing ionic strength (typically 0-500 mM NaCl)
Implement affinity chromatography using the incorporated tag (if applicable)
Follow with size exclusion chromatography to remove aggregates and achieve final polishing
Confirm purity via SDS-PAGE (≥95% homogeneity)
Verify identity through Western blotting and/or mass spectrometry
This multi-step approach typically yields protein with >95% purity suitable for structural and functional studies.
Comprehensive characterization of Recombinant Pantoea vagans Protein AaeX should include:
MS/MS peptide mapping to confirm sequence identity
N-terminal sequencing to verify correct processing
Circular dichroism (CD) spectroscopy to determine α-helical content
FTIR spectroscopy for complementary secondary structure information
NMR spectroscopy for solution structure (challenging for membrane proteins)
X-ray crystallography if crystals can be obtained
Liposome reconstitution assays to evaluate membrane integration
Binding assays with potential interacting partners
Differential scanning calorimetry to determine thermal stability
Storage stability tests at various conditions (-20°C, -80°C with 50% glycerol)
Table 1: Recommended Characterization Methods for Recombinant AaeX Protein
Analysis Type | Method | Information Obtained | Sample Requirements |
---|---|---|---|
Identity | MS/MS | Sequence confirmation | 10-50 μg, high purity |
Structure | CD Spectroscopy | Secondary structure | 0.1-0.5 mg/mL, >90% pure |
Function | Liposome Assays | Membrane integration | 100-200 μg, active protein |
Stability | Thermal Shift | Thermal stability (Tm) | 50-100 μg, >85% pure |
Implementing DoE methodologies can significantly enhance recombinant AaeX production by identifying optimal conditions while minimizing experimental runs:
Expression temperature (typically 16-37°C)
Inducer concentration (e.g., IPTG 0.1-1.0 mM)
Post-induction time (4-24 hours)
Media composition (standard vs. enriched)
Cell density at induction (OD600 0.4-1.0)
Implement a full or fractional factorial design to screen factors
For example, a 2³ factorial design examining temperature, inducer concentration, and induction time would require 8 experimental conditions
Analyze results using statistical software (e.g., JMP, Minitab)
Generate response surface models to identify optimal conditions
Validate optimized conditions with confirmation runs
This DoE approach has been successfully applied to similar recombinant protein production systems, as demonstrated in the AAV particle enrichment study . For membrane proteins like AaeX, this approach is particularly valuable for balancing expression level with proper folding.
When encountering data inconsistencies in AaeX research, implement the following systematic approach:
Apply exploratory data analysis techniques to identify patterns and outliers5
Use histogram and box plot analysis to visualize data distribution
Implement statistical tests to identify significant deviations
Standardize protein batches using validated quantification methods
Implement strict temperature and pH control during experiments
Document detailed reagent sources and lot numbers
Perform method validation studies including:
Precision (intra-assay and inter-assay variability)
Accuracy (recovery tests)
Linearity (response across concentration ranges)
Specificity (cross-reactivity assessments)
When possible, verify critical findings through collaborative studies
Implement blinded sample analysis to minimize bias
Table 2: Common Sources of Inconsistency in AaeX Research and Mitigation Strategies
Source of Inconsistency | Detection Method | Mitigation Strategy |
---|---|---|
Protein heterogeneity | SDS-PAGE, SEC-MALS | Optimize purification protocol |
Detergent effects | Functional assays with different detergents | Standardize detergent type and concentration |
Buffer composition | pH/conductivity monitoring | Prepare fresh buffers, validate components |
Instrument variability | Regular calibration checks | Implement system suitability tests |
Low yields of Recombinant Pantoea vagans Protein AaeX can be systematically addressed through the following troubleshooting workflow:
Verify vector construction through sequencing
Test multiple expression strains (BL21, C41/C43 for membrane proteins)
Optimize codon usage for the expression host
Reduce expression temperature to 16-20°C to improve folding
Evaluate different induction strategies (IPTG concentration, induction timing)
Screen multiple detergents (DDM, LDAO, Fos-choline)
Optimize detergent-to-protein ratio
Extend solubilization time (4-16 hours)
Test different buffer compositions (pH 6.5-8.5)
Implement mild wash conditions during affinity chromatography
Minimize concentration steps to prevent aggregation
Add stabilizing agents (glycerol, specific lipids)
Store protein in Tris-based buffer with 50% glycerol at -20°C or -80°C
Avoid repeated freeze-thaw cycles
Add protease inhibitors to prevent degradation
This systematic approach typically improves yields by 2-5 fold compared to standard protocols.
To investigate potential interactions between Recombinant Pantoea vagans Protein AaeX and lipopolysaccharides (LPS), consider these methodological approaches:
Surface Plasmon Resonance (SPR)
Immobilize purified AaeX on a sensor chip
Flow purified LPS over the surface at various concentrations
Determine binding kinetics (kon, koff) and affinity (KD)
Microscale Thermophoresis (MST)
Label either AaeX or LPS with a fluorescent dye
Measure changes in thermophoretic mobility upon binding
Calculate binding parameters in near-native solution conditions
Liposome Co-reconstitution
Incorporate AaeX and LPS into synthetic liposomes
Measure changes in membrane properties or permeability
Compare with control liposomes lacking either component
Membrane Model Systems
Use supported lipid bilayers containing AaeX
Visualize interactions with LPS using atomic force microscopy
Heterologous Expression Systems
Several cutting-edge technologies are particularly promising for advancing structural understanding of membrane proteins like AaeX:
Single-particle analysis for high-resolution structures without crystallization
Ideal for membrane proteins that resist crystallization
Can reveal dynamic conformational states
Combining multiple techniques (NMR, SAXS, computational modeling)
Allows for structure determination in near-native environments
Particularly valuable for membrane proteins like AaeX
AlphaFold2 and RoseTTAFold for accurate structure prediction
Molecular dynamics simulations to study membrane integration
Predicted AaeX structures can guide experimental design
Analyzes intact membrane protein complexes
Reveals protein-lipid interactions
Maintains native protein fold during analysis
Incorporates AaeX into defined lipid environments
Enables solution-state structural studies
Provides a more native-like environment than detergent micelles
These emerging approaches can overcome traditional challenges in membrane protein structural biology and provide unprecedented insights into AaeX structure-function relationships.
High-throughput methodologies can dramatically accelerate functional characterization of AaeX through parallel experimentation and automated analysis:
Test multiple constructs, tags, and expression conditions simultaneously
Use fluorescent reporters to monitor expression levels
Implement automated cell lysis and protein detection
Develop parallelized chromatography workflows
Implement liquid handling robotics for consistent processing
Use technologies like the Stunner® for rapid analysis of multiple samples simultaneously
Immobilize AaeX variants on microarray surfaces
Screen for interactions with multiple potential binding partners
Analyze binding profiles across thousands of conditions
Express fluorescently tagged AaeX in cellular models
Track localization, trafficking, and interactions
Quantify phenotypic changes following genetic or chemical perturbations
Design 96- or 384-well compatible assays for AaeX function
Screen across multiple conditions simultaneously
Implement appropriate controls for statistical validation
Table 3: Comparison of High-Throughput Methods for AaeX Characterization
Method | Throughput | Sample Requirement | Key Advantage | Limitation |
---|---|---|---|---|
Stunner® Analysis | 96 samples/70 min | 2 μL/sample | Simultaneous UV-Vis, DLS, SLS analysis | Specialized equipment required |
Microfluidic Assays | >1000 conditions/day | <1 μL/condition | Minimal sample consumption | Method development complexity |
Automated Chromatography | 8-24 samples/day | 1-5 mg protein | Consistent purification | Higher protein requirements |
Biolayer Interferometry | 96 samples/run | 50-100 μg protein | Real-time binding analysis | Surface immobilization artifacts |